XORTX Therapeutics Inc. (XRTX) - Latest Market Data

Price & Market Data

Price: $2.28

Daily Change: -$0.0311 / 1.36%

Daily Range: $2.07 - $2.28

Market Cap: $3,772,629

Daily Volume: 22,466

Performance Metrics

1 Week: 4.31%

1 Month: -13.15%

3 Months: 11.51%

6 Months: -17.42%

1 Year: -55.05%

YTD: -23.39%

About XORTX Therapeutics Inc. (XRTX)

Comprehensive analysis of XORTX Therapeutics Inc. (XRTX). Currently at 2.28, with a daily change of -$0.0311 / 1.36%. Market cap: 3,772,629. Evaluate its performance over YTD, 1-month, and 6-month periods.

Details

XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat hyperuricemia related diseases in Canada. It develops XRx-026, which is in Phase III for the treatment of gout; XRx-008, which is in Phase II for the treatment of autosomal dominant polycystic kidney disease; XRx-101, which is in Phase II for the treatment of acute kidney injury associated with respiratory virus infection, including sepsis and coronavirus; and XRX-225, which is in preclinical stage for the treatment of type 2 diabetic nephropathy, as well as VB4-P5, a program for the treatment and prevention of fibrosis in the kidney. The company is based in Calgary, Canada.

Selected stocks

Uranium Royalty Corp. (UROY)

Lite Strategy, Inc. (LITS)

AMTD Digital Inc. (HKD)

OPAL Fuels Inc. (OPAL)

GIBO Holdings Limited (GIBO)